Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events

Show other versions (1)

Immune checkpoint inhibitors are able to reactivate the immune system therefore enhance the anti-tumor effects. However, over-activated T cells may induce immune related adverse events (irAEs). Hematological irAEs are rarely reported, which mainly represent as mono-lineage cytopenia or pancytopenia,...

Full description

Bibliographic Details
Main Authors: Junling ZHUANG, Jingting ZHAO, Xiaoxiao GUO, Jiaxin ZHOU, Lian DUAN, Wei QIU, Xiaoyan SI, Li ZHANG, Yue LI, Xiaowei LIU, Hanping WANG, Daobin ZHOU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-10-01
Series:Chinese Journal of Lung Cancer
Subjects:
Immune checkpoint inhibitor
Immune-related adverse events
Cytopenia
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.13

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.13

Similar Items